selected publications
-
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.
Transfusion.
2022
Academic Article
GET IT
Times cited: 2 -
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.
Blood advances.
2022
Academic Article
GET IT
Times cited: 9 -
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.
Blood advances.
2022
Academic Article
GET IT
Times cited: 4 -
Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
2021
GET IT
Times cited: 1 -
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Transplantation and cellular therapy.
2021
Academic Article
GET IT
Times cited: 6 - A simplified CD34+ based preharvest prediction tool for HPC(A) collection. Transfusion. 2021 Academic Article GET IT
-
Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
2021
GET IT
Times cited: 4 -
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.
Blood advances.
2020
Academic Article
GET IT
Times cited: 12 -
Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.
Blood reviews.
2020
Review
GET IT
Times cited: 11 - Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34+-selected allogeneic transplantation. Advances in cell and gene therapy. 2020 Academic Article GET IT
-
Guidelines for Cord Blood Unit Thaw and Infusion.
2020
GET IT
Times cited: 4 -
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.
Leukemia.
2020
Academic Article
GET IT
Times cited: 7 -
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2020
Academic Article
GET IT
Times cited: 5 -
A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients.
2020
GET IT
Times cited: 1 -
Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness.
2019
GET IT
Times cited: 5 -
Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma.
Leukemia.
2019
Letter
GET IT
Times cited: 20 -
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 13 -
Evaluation of peripheral blood mononuclear cell collection by leukapheresis.
Transfusion.
2019
Academic Article
GET IT
Times cited: 12 -
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 6 -
Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah's Witness with hemorrhagic shock.
2018
GET IT
Times cited: 7 - Method comparison study of peripheral blood CD34+ count performed on an Abbott CELL-DYN Sapphire hematology analyzer versus flow cytometry reference procedure (modified ISHAGE). Advances in cell and gene therapy. 2018 Academic Article GET IT
-
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
Bone marrow transplantation.
2017
Academic Article
GET IT
Times cited: 8 -
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 12 -
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 9 -
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 8 -
Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 29 -
How do I perform hematopoietic progenitor cell selection?.
Transfusion.
2016
Review
GET IT
Times cited: 16 -
Can the interval between antibody identifications be increased for alloimmunized patients?.
Transfusion.
2015
Academic Article
GET IT
Times cited: 6 -
Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products.
Transfusion.
2015
Academic Article
GET IT
Times cited: 7 -
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
Transfusion.
2015
Academic Article
GET IT
Times cited: 12 -
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center.
Transfusion.
2012
Academic Article
GET IT
Times cited: 29 -
Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
American journal of clinical pathology.
2012
Academic Article
GET IT
Times cited: 69 -
Functional heterogeneity of the bone marrow vascular niche.
Annals of the New York Academy of Sciences.
2009
Academic Article
GET IT
Times cited: 53 -
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.
The Journal of clinical investigation.
2006
Academic Article
GET IT
Times cited: 88 -
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.
Nature medicine.
2006
Academic Article
GET IT
Times cited: 564 -
The bone marrow vascular niche: home of HSC differentiation and mobilization.
Physiology (Bethesda, Md.).
2005
Review
GET IT
Times cited: 420 -
Tie2 activation contributes to hemangiogenic regeneration after myelosuppression.
Blood.
2005
Academic Article
GET IT
Times cited: 104 -
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
Nature medicine.
2003
Academic Article
GET IT
Times cited: 604 -
Tumor vasculature address book: identification of stage-specific tumor vessel zip codes by phage display.
Cancer cell.
2003
Comment
GET IT
Times cited: 42 -
Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment.
Annals of the New York Academy of Sciences.
2003
Academic Article
GET IT
Times cited: 121